NCT00372112 - A Study To Assess The Safety And Tolerability Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 3, 2006

Primary Completion Date

May 1, 2007

Study Completion Date

May 10, 2007

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GW642444

GW642444H

OTHER

Placebo

Placebo administered twice daily

Trial Locations (14)

GSK Investigational Site, Auckland

GSK Investigational Site, Sofia

GSK Investigational Site, Sofia

GSK Investigational Site, Camperdown

GSK Investigational Site, Nedlands

GSK Investigational Site, Rousse

GSK Investigational Site, Geesthacht

GSK Investigational Site, Hanover

GSK Investigational Site, Weinheim

GSK Investigational Site, Iași

GSK Investigational Site, Breda

GSK Investigational Site, Hoorn

GSK Investigational Site, Tauranga

GSK Investigational Site, Bucharest